核 Akt 機能に対抗する腫瘍抑制ネットワークの識別
Lloyd C Trotman1, Andrea Alimonti, Pier Paolo Scaglioni
1Cancer Biology and Genetics Program, Memorial Sloan-Kettering Cancer Center, Sloan-Kettering Institute, 1275 York Avenue, New York, New York 10021, USA.
Nature
|May 9, 2006
まとめ
PML腫瘍抑制剤は,核AKTを非活性化することによって,がんを予防します. PMLの喪失は癌を加速し,FOXO転写因子を損なっており,がんにおけるAKTの区分化を強調しています.
科学分野:
- 腫瘍学 腫瘍学
- 分子生物学は分子生物学である.
- 細胞生物学 細胞生物学
背景:
- プロトオンコゲンAKTは,多くのヒトの癌で活性化され,しばしばPTEN喪失によるものです.
- 細胞膜で活性化されたAKTは,FOXO転写因子のような核標的をリン酸化しますが,腫瘍発生における核の役割は不明です.
研究 の 目的:
- 核AKT活性調節におけるPML腫瘍抑制剤の役割とその腫瘍発生への影響について調査する.
主な方法:
- Pten-ヘテロジゴス変異を持つマウスモデルを使用して,Pml損失の影響を研究しました.
- Pml核体におけるAKTとPP2aの局所化と活性について調査した.
- FOXO転写因子活動と下流目標に対するPml欠乏の影響を評価した.
主要な成果:
- PML喪失は,Pten-ヘテロジゴスマウスにおける腫瘍発症,発生,および進行を加速した.
- PML欠乏症は前立腺腫瘍形成と女性の不妊症を引き起こし,Foxo3aのノックアウト現象を模倣した.
- PmlはAKTフォスファタゼPP2aとpAKTを核体に誘導し,Pml-null細胞はPP2aの活性が低下し,核pAKTの蓄積につながります.
- Pml濃度の低下は,Fox3a媒介によるBimとp27の転写の不活性化をもたらした.
結論:
- PMLは,核AKTを無効化することによって,核腫瘍抑制剤として作用します.
- PMLは,核のAKTを制御するための核ネットワークを編成し,がんにおけるAKTの区分化の重要性を強調しています.
- PMLの機能は,がん治療におけるAKT局所化を標的とした潜在的な治療戦略を強調しています.
さらに関連する動画
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
09:33Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor
Published on: August 25, 2023
関連する概念動画
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:22PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...